← Back to Search

Trauma-Informed Toolkit for HIV Prevention in African American Women

N/A

Waitlist Available

Led By Tiara C. Willie, PhD

Research Sponsored by Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 8-months after toolkit implementation in each clinic

Awards & highlights

Study Summary

This trial seeks to develop a toolkit to increase pre-exposure prophylaxis uptake among African American women in the south who experience high rates of intimate partner violence.

Who is the study for?

This trial is for African American women receiving care at community healthcare clinics in Mississippi, who are at risk for HIV infection and may also be dealing with intimate partner violence. Participants must speak and understand English.Check my eligibility

What is being tested?

The study is testing a Trauma-Informed Toolkit designed to increase the use of Pre-Exposure Prophylaxis (PrEP) among African American women. It aims to address both HIV prevention and intimate partner violence within two clinics in Jackson, Mississippi.See study design

What are the potential side effects?

Since this trial involves the implementation of an educational toolkit rather than a medical intervention, there are no direct side effects from medications or treatments being studied.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 8-months after toolkit implementation in each clinic

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 8-months after toolkit implementation in each clinic

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 8-months after toolkit implementation in each clinic for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pre-Exposure Prophylaxis

Secondary outcome measures

Clinic's %Pre-Exposure Prophylaxis Uptake

Clinic's Pre-Exposure Prophylaxis Coverage

Clinic's proportion of women with Pre-Exposure Prophylaxis retention

Trial Design

1Treatment groups

Experimental Treatment

Group I: Trauma-Informed Pre-Exposure Prophylaxis Implementation ToolkitExperimental Treatment1 Intervention

The Toolkit to be developed in the proposed study includes components from the women-specific Pre-Exposure Prophylaxis care continuum theoretical model and implementation challenges, and is adapted to identify and provide care to women experiencing intimate partner violence. Overall, the Toolkit is designed to create culturally-congruent, intimate partner violence-informed clinical settings; and equip clinical staff with the knowledge and skills they need to address HIV prevention for African American women; and integrate intimate partner violence into Pre-Exposure Prophylaxis care services.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor

410 Previous Clinical Trials

2,116,900 Total Patients Enrolled

Tiara C. Willie, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health

Media Library

Trauma-Informed Toolkit Clinical Trial Eligibility Overview. Trial Name: NCT05139069 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Trauma-Informed Pre-Exposure Prophylaxis Implementation Toolkit

Human Immunodeficiency Virus Infection Clinical Trial 2023: Trauma-Informed Toolkit Highlights & Side Effects. Trial Name: NCT05139069 — N/A

Trauma-Informed Toolkit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05139069 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still room for enrolment in this clinical experiment?

"The clinical trial's data available on clinicaltrials.gov indicates that, at present, it isn't seeking participants. It was first posted October 31st 2021 and updated November 4th 2022; however, 503 other medical studies are actively recruiting patients presently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American Women

2021. "Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American Women". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05139069.

All > Domestic Violence